The department of war (DOW) drug demand reduction program (DDRP) has a requirement for FDA and quality management documented THC9-cooh immunoassay reagent kits for use with the currently installed…
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- N0018926DB003
- Awardee
-
Microgenics Corporation UEI E7WGWEK19Y79
- Awarding agency
-
Naval Supply Systems Command
Department of the Navy, Department of Defense
- Task orders
- 0
Award facts
- Last date to order 5% complete
- IDV ceiling
- $775,453.50
- Maximum order
- $140.10
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- Funding agency
- Bureau of Medicine and Surgery Department of the Navy, Department of Defense
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Two Step
- Pricing
- Order Dependent (IDV only)
Award details come from SAM.gov/FPDS.
About this IDV
The Department of the Navy Bureau of Medicine and Surgery awarded a single-award indefinite-delivery contract to Microgenics Corporation for FDA and quality management documented THC9-COOH immunoassay reagent kits compatible with Beckman Coulter AU5800 series systems, with a ceiling of $775,453.50 and an award date of August 1, 2026. The contract carries no set-aside designation. Performance runs through July 31, 2031.
Work is performed primarily at Microgenics' facility in Fremont, California, with subordinate manufacturing and fulfillment locations at San Antonio, Texas; Pomona, California; and Waukegan, Illinois, and delivery to military medical treatment facilities and Veterans Affairs centers nationwide and overseas. The contract falls under NAICS 325413 (In-Vitro Diagnostic Substance Manufacturing) and PSC 6550 (In Vitro Diagnostic Substances, Reagents, Test Kits and Sets).
Microgenics is a Clinical Diagnostics Division subsidiary of Thermo Electron Corporation and operates as a pure prime contractor with no subcontract activity. The vendor holds a concentrated federal portfolio centered on immunoassay reagents for the Department of Defense Drug Demand Reduction Program, with five primary indefinite-delivery contract vehicles established with Navy BUMED and Veterans Integrated Service Network 23. Recent task-order activity under related Microgenics vehicles includes a $175.7 million benzodiazepine reagent kit order to Air Education and Training Command (December 16, 2025) and a $163.9 million benzodiazepine order for Tripler Army Medical Center, Hawaii (April 21, 2026).
Description
The department of war (DOW) drug demand reduction program (DDRP) has a requirement for FDA and quality management documented THC9-cooh immunoassay reagent kits for use with the currently installed beckman coulter AU5800 series systems.
Quick answers
Who was awarded contract N0018926DB003?
N0018926DB003 was awarded to Microgenics Corporation by Naval Supply Systems Command (Department of the Navy) on August 1, 2026.
How much is contract N0018926DB003 worth?
N0018926DB003's own ceiling is $775,454. A single order can be worth up to $140.
Which agency awarded contract N0018926DB003?
Naval Supply Systems Command (Department of the Navy) awarded N0018926DB003, with funding from Bureau of Medicine and Surgery (Department of the Navy).
Who can order from contract N0018926DB003?
N0018926DB003 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract N0018926DB003 competed?
The extent of competition for N0018926DB003 was full and open competition. The government received 3 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV